158 Osimertinib for Sale
AZD-9291 99% white powder cas1421373-65-0 senwayer
-
CAS No.:
1421373-65-0
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
1kg/bag
API,nutrition supplements,plant extract,peptide,HCG
Verified supplier certificate,SGS
Osimertinib 99% white powder GB0301 Greenbo
-
CAS No.:
1421373-65-0
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
25kg Drum
Active Pharm Ingredients,Chemical Catalyst,Pharmaceutical Intermediates,Flavors and Fragrances,Agrochemicals,Chemical Pesticides,Organic Intermediates,OLED Intermediates
FSSC2000,international trade license
Osimertinib AZD9291 99% Power USP/EP/JP/CP JINLAN PHARM
-
CAS No.:
1421373-65-0
-
Grade:
Pharmaceutical grade
-
Content:
99%
-
Packaging:
25Kg/drum
additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst,API
99% Purity Pharmaceutical Raw Osimertinib Powder Azd-9291 Mesylate for Lung Cancer
-
CAS No.:
1421373-65-0
-
Content:
0.00%
-
Packaging:
Foil Bag
Herb Extracts,Cosmetic raw materails,API
Airuike Osimertinib (AZD9291)
-
CAS No.:
1421373-65-0
-
Grade:
Industrial Grade
-
Content:
99%
-
Packaging:
25kg/Cardboard Drum
api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVE
Credit rating certificate,Hazardous Chemicals Business License
Products You May Be Interested in
Osimertinib (AZD9291)
-
CAS No.:
1421373-65-0
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
25kg Carboard Crub
Terbinafine hydrochloride,Carboplatin,Pramipexole dihydrochloride Monohydrate,Cisatracurium Besylate,Rivaroxaban,Lenvatinib,Febuxostat,Pemetrexed,Capecitabine,Oxaliplatin,Cisplatin,Ezetimibe,Mitiglinide Calcium,Lapatinib,Dasatinib,Osimertinib,Olaparib,Palbociclib,Lenalidomide,Bortezomib,Enzalutamide,Pemetrexed disodium heptahydrate,Ropivacaine HCL,Atracurium Besylate,Racecadotril,Apremilast,Vonoprazan Fumarate,Crisaborole,Rimegepant
Osimertinib 1421373-65-0
-
CAS No.:
1421373-65-0
-
Packaging:
5kg/tin
Levetiracetam,Acitretin,Tranexamic Acid,Isotretinoin,Brimonidine Tartrate,5-Hydroxy-4-methyl-2-5(H)-furanone
AZD-9291
-
CAS No.:
1421373-65-0
-
Grade:
Industrial Grade
-
Content:
98%
-
Packaging:
2.5 g/unit
nucleotides,APIs,carbohydrates,nucleosides,stem cell molecule,inhibitors,ADCs,chiral compounds,building blocks,natural compounds,GMP Products
AZD-9291 C28H33N7O2
-
CAS No.:
1421373-65-0
-
Grade:
Pharmaceutical Grade
-
Content:
98%
-
Packaging:
25kg/bag
Glutathione,Arbutin,Kojic acid,Polycaprolactone,Hydroxyapatite,EMT,Phase Change Microcapsule,AVC powder,PLLA,PLGA,API
Cooling agent certificate,Business certificate
AZD-9291
-
CAS No.:
1421373-65-0
-
Content:
99.00%
-
Packaging:
Bottle,barrel,cargo,container,etc.
Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
ISO
- If you want to buy Osimertinib, then ECHEMI will offer you multi-options. The suppliers of 158 Osimertinib on the search result are been verified by the accurate information of each one. Accurate information is the prerequisite of transaction. Find your Osimertinib order with 70000+ buyers on ECHEMI.
- The quality of Osimertinib 1421373-65-0 will be secured by ECHEMI. The pursuit of high quality requires all partners of ECHEMI to be screened, whether its certificate, qualification or scale. Osimertinib will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We are providing better products and services of Osimertinib with fair price and reasonable deal. Registered member can enjoy more services of Osimertinib on with market price and insights, global news, trade data and so on. Efficient order options is the key for supply chain services we offer for you. We will help you purchase Osimertinib and run fast your business.
- •Challenge to AstraZeneca's Cancer Drug as Synlogic's TY-9591 Outperforms Osimertinib
- •Osimertinib Faces Patent Crisis, $100 Million Compensation Remains Unsettled, Lung Cancer Treatment Market Faces Uncertainty!
- •AstraZeneca Announces FDA Priority Review for Osimertinib
- •Breakthroughs in Osimertinib and Three Other Investigational Drugs by Ascentage Pharma Revealed at AACR Annual Meeting
- •Colonbotai SKB264 (MK-2870) combined with osimertinib was approved for clinical trials